Subcutaneous Depot Leuprorelin: A Viewpoint by Navjeet Gandhok and Oliver Sartor

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.3, Iss.3, 2004-01, pp. : 203-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leuprorelin: Subcutaneous Depot Formulation (Eligard®) for Advanced Prostate Cancer

By Evans Hannah C. Wagstaff Antona J.

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 197-201

Adis International

Access to resources Recommend Favorite

Professor Raymond Oliver, 1921-1976

By Alper Tikvah

International Journal of Radiation Biology, Vol. 29, Iss. 5, 1976-05 ,pp. : 399-399

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine: A Viewpoint by Werner Scheithauer

By Scheithauer Werner

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 324-325

Adis International

Access to resources Recommend Favorite

A brief introduction to Fu's subcutaneous needling

By Fu Zhong-Hua Xu Jian-Guo

The Pain Clinic, Vol. 17, Iss. 3, 2005-09 ,pp. : 343-348

Maney Publishing

Access to resources Recommend Favorite

Cutaneous and subcutaneous metastases of rectal cancer

By Sarid David Wigler Nely Gutkin Zeev Merimsky Ofer Leider-Trejo Leonore Ron Ilan G.

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 202-205

Springer Publishing Company

Access to resources Recommend Favorite